Role of 5-HT(2A) receptor antagonists in the treatment of insomnia

Por Vanover, Kimberly E, Davis, Robert E
Publicado em 2010

Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, 
Present and Future

Por Li, Peng, Snyder, Gretchen L., Vanover, Kimberly E.
Publicado no Curr Top Med Chem (2016)

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

Por Warner-Schmidt, Jennifer L., Vanover, Kimberly E., Chen, Emily Y., Marshall, John J., Greengard, Paul
Publicado em 2011

Pimavanserin tartrate, a 5-HT(2A) Receptor Inverse Agonist, Increases Slow Wave Sleep as Measured by Polysomnography in Healthy Adult Volunteers

Por Ancoli-Israel, Sonia, Vanover, Kimberly E., Weiner, David M., Davis, Robert E., van Kammen, Daniel P.
Publicado em 2011

A 5-HT(2A) receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

Por Vanover, Kimberly E., Betz, Adrienne J., Weber, Suzanne M., Bibbiani, Francesco, Kielaite, Aiste, Weiner, David M., Davis, Robert E., Chase, Thomas N., Salamone, John D.
Publicado em 2008

Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats

Por Snyder, Gretchen L., Prickaerts, Jos, Wadenberg, Marie-Louise, Zhang, Lei, Zheng, Hailin, Yao, Wei, Akkerman, Sven, Zhu, Hongwen, Hendrick, Joseph P., Vanover, Kimberly E., Davis, Robert, Li, Peng, Mates, Sharon, Wennogle, Lawrence P.
Publicado no Psychopharmacology (Berl) (2016)

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

Por Snyder, Gretchen L., Vanover, Kimberly E., Zhu, Hongwen, Miller, Diane B., O’Callaghan, James P., Tomesch, John, Li, Peng, Zhang, Qiang, Krishnan, Vaishnav, Hendrick, Joseph P., Nestler, Eric J., Davis, Robert E., Wennogle, Lawrence P., Mates, Sharon
Publicado no Psychopharmacology (Berl) (2014)